AAP
IDYA icon

Arax Advisory Partners’s IDEAYA Biosciences IDYA Stock Holding History

Arax Advisory Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58
Closed -$2.01K – 4053
2025
Q4 		$2.01K Sell
58
-232
-80% -$7.4K ﹤0.01% 3261
2025
Q3 		$7.89K Buy
+290
New +$7.01K ﹤0.01% 2696

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Arax Advisory Partners's IDYA Position: Q1 2026 in Review

Arax Advisory Partners sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 58 shares — an estimated $2.01K sold.

Arax Advisory Partners first reported a position in IDYA in Q3 2025 and held it in 2 quarters. The position peaked at $7.89K in Q3 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Arax Advisory Partners reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Arax Advisory Partners sold 58 IDEAYA Biosciences shares in Q1 2026, an estimated $2.01K.
  • Arax Advisory Partners first reported a position in IDEAYA Biosciences in Q3 2025 and held it in 2 quarters.
  • Arax Advisory Partners's IDEAYA Biosciences position peaked at $7.89K in Q3 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.